Patents Assigned to CULLINAN PEARL CORP.
  • TREATMENT REGIMENS FOR EXON-20 INSERTION MUTANT EGFR CANCERS
    Publication number: 20230372346
    Abstract: Treatment regimens for exon 20 insertion mutant cancers with (S)—N-(4-amino-6-methyl-5-(quinolin-3-yl)-8,9-dihydropyrimido[5,4-b]indolizin-8-yl)acrylamide (Compound 1).
    Type: Application
    Filed: September 7, 2021
    Publication date: November 23, 2023
    Applicant: CULLINAN PEARL CORP.
    Inventors: Briggs MORRISON, Jon WIGGINTON, David WITTER, Leigh ZAWEL, Myles CLANCY